KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Shares Outstanding (Weighted Average): 2010-2024

Historic Shares Outstanding (Weighted Average) for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $54.2 million.

  • Emergent BioSolutions' Shares Outstanding (Weighted Average) rose 0.84% to $53.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.4 million, marking a year-over-year increase of 0.84%. This contributed to the annual value of $54.2 million for FY2024, which is 4.43% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Shares Outstanding (Weighted Average) of $54.2 million as of FY2024, which was up 4.43% from $51.9 million recorded in FY2023.
  • Emergent BioSolutions' Shares Outstanding (Weighted Average)'s 5-year high stood at $54.2 million during FY2024, with a 5-year trough of $49.9 million in FY2022.
  • Over the past 3 years, Emergent BioSolutions' median Shares Outstanding (Weighted Average) value was $51.9 million (recorded in 2023), while the average stood at $52.0 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first declined by 7.27% in 2022, then rose by 4.43% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Shares Outstanding (Weighted Average) (Yearly) stood at $53.0 million in 2020, then grew by 1.51% to $53.8 million in 2021, then declined by 7.27% to $49.9 million in 2022, then climbed by 4.00% to $51.9 million in 2023, then rose by 4.43% to $54.2 million in 2024.